ROAD - ROAD

Construction Partners Bolsa (NASDAQ: ROAD)

Últimas noticias sobre Construction Partners (NASDAQ:ROAD) Bolsa

Construction Partners

Construction Partners Inc operates as a civil infrastructure company. It specializes in the construction and maintenance of roadways. The company through its subsidiaries, provides various products and services to both public and private infrastructure projects, with an emphasis on highways, roads, bridges, airports, and commercial and residential developments. Its operations consist of manufacturing and distributing hot mix asphalt, paving activities, including the construction of roadway base layers and application of asphalt pavement, site development, including the installation of utility and drainage systems, and others. The company has a single segment which predominantly consists of infrastructure and road construction, and operates across various states in the United States.

Stock Whisper Index

Short Sellers

Exclusives

Trading Ideas

CWST

ROAD

Explora las acciones emergentes que podrían dispararse pronto según el análisis del Índice Stock Whisper de Benzinga.

Índice Stock Whisper de Benzinga revela 5 acciones con potencial de crecimiento antes de reportes

Brian Armstrong, CEO of Coinbase, recalled an old encounter with Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>) co-founder Vitalik Buterin and the inefficiencies of the U.S. immigration system that contributed to the blockchain&#8217;s creation.
What Happened:&nbsp;In an X post on Wednesday, Armstrong shared a personal anecdote about meeting Buterin in 2013 at a Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) conference in San Jose. This was when Buterin was involved with Bitcoin Magazine, a publication he co-founded.
Armstrong said he invited Buterin to visit Coinbase's office in San Francisco, where the team was impressed by his work and tried to hire him.
&#8220;But due to a series of circumstances, including him not being able to get a work visa in the U.S., it didn&#8217;t work out, and he had to go back to Canada,&#8221; Armstrong said.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Ethereum. Fun fact: I met <a href="https://twitter.com/VitalikButerin?ref_src=twsrc%5Etfw">@VitalikButerin</a> in 2013 at the San Jose Bitcoin conference when he was writing for Bitcoin Magazine (his writing was great). A few months later I invited him to come by Coinbase&#39;s first office in San Francisco for a visit and he showed us some cool… <a href="https://t.co/VPkq6BcX1j">https://t.co/VPkq6BcX1j</a>
&mdash; Brian Armstrong (@brian_armstrong) <a href="https://twitter.com/brian_armstrong/status/1950581739174453251?ref_src=twsrc%5Etfw">July 30, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
&#8220;While he was stuck in&nbsp;Canada, he created Ethereum,&#8221; he narrated further. &#8220;So,&nbsp;in a way, the sub-optimal&nbsp;immigration system in the U.S.&nbsp;contributed to the creation of&nbsp;Ethereum.&#8221;
See Also:&nbsp;<a href="https://www.benzinga.com/crypto/cryptocurrency/25/07/46713430/bitcoin-creator-satoshi-nakamoto-once-said-he-had-no-time-to-convince-non-believers-why-coinbase-ceo-brought-it-up-after-15-years">Bitcoin Creator Satoshi Nakamoto Once Said He Had No Time To &#8216;Convince&#8217; Non-Believers: Why Coinbase CEO Brought It Up After 15 Years</a>
Why It Matters:&nbsp;Armstrong&#8217;s anecdote came in the wake of Ethereum&#8217;s 10th anniversary, marking a decade of influence in the world of cryptocurrencies and blockchain technology.
The blockchain was <a href="https://www.benzinga.com/money/what-is-ethereum">proposed in late 2013</a> by Russian-born computer programmer Buterin, its development crowdfunded in 2014 before going live on July 30, 2015. Its key innovation is its smart contract functionality, which allows for the execution of code exactly as programmed without censorship or third-party interference.
Today, it is the biggest smart contract network, with a whopping $84 billion worth of value locked, <a href="https://defillama.com/chains">according </a>to DeFiLlama. Additionally, its native cryptocurrency Ether is the world&#8217;s second-largest, boasting a market capitalization of $465 billion.
Read Next:&nbsp;
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/crypto/cryptocurrency/25/07/46720222/ethereums-rally-driven-by-fresh-inflows-not-a-rotation-out-of-bitcoin-report">Ethereum&#8217;s Rally Driven By Fresh Inflows, Not A Rotation Out Of Bitcoin: Report</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of&nbsp;<a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a>&nbsp;and was reviewed and published by Benzinga editors.<a href="https://www.benzinga.com/apis?utm_source=benzinga.com&amp;utm_campaign=article-bottom" rel="noreferrer noopener" target="_blank"></a>
Photo: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

$ETH

COIN

Coinbase CEO Brian Armstrong Recalls How US Immigration Woes Helped Spark Ethereum's Creation

Full Year 2025 Financial Guidance
Biogen is raising its full year 2025 financial guidance reflecting an expected stronger business outlook for the full year. Full year 2025 Non-GAAP diluted EPS range is expected as follows:
<figure class="table"> 
<table>
<tbody>
<tr>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
</tr>
<tr>
<td colspan="3">&nbsp;</td>
<td colspan="3">&nbsp;</td>
<td colspan="3">Full Year 2025 Non-GAAP Diluted EPS</td>
</tr>
<tr>
<td colspan="3">Prior Guidance (May 2025)</td>
<td colspan="3">&nbsp;</td>
<td colspan="3">$14.50 to $15.50</td>
</tr>
<tr>
<td colspan="3">Benefit from stronger business outlook</td>
<td colspan="3">&nbsp;</td>
<td colspan="3">+$0.87</td>
</tr>
<tr>
<td colspan="3">Approx. impact from City Therapeutics transaction</td>
<td colspan="3">&nbsp;</td>
<td colspan="3">($0.12)</td>
</tr>
<tr>
<td colspan="3">Updated Guidance</td>
<td colspan="3">&nbsp;</td>
<td colspan="3">$15.50 to $16.00</td>
</tr>
</tbody>
</table>
</figure>
This updated Non-GAAP diluted EPS guidance range reflects an $0.87 benefit from an expected stronger business outlook for the full year, partially offset by the ~($0.12) impact from the City Therapeutics transaction.
For 2025 as compared to 2024, Biogen expects total revenue to be approximately flat, at constant currency, up from a mid-single digit decline previously. This reflects the strong first half revenue performance, including the resilient performance of the U.S. MS business. Biogen expects increased competitive pressures on the ex-U.S. MS business in the second half of 2025, particularly for TECFIDERA in Europe. Due to planned plant maintenance activities, Biogen expects minimal contract manufacturing revenue in the fourth quarter of 2025.
The Fit for Growth program is expected to generate approximately $1 billion of gross savings and $800 million net of reinvestment by the end of 2025. In 2025, Biogen plans to make additional investments in R&amp;D to enable acceleration and expansion of the clinical development activities, primarily in support of rare disease. Biogen expects combined Non-GAAP R&amp;D expense and Non-GAAP SG&amp;A expense to total approximately $4.0 billion in 2025.
This financial guidance incorporates the Company's view that Biogen's 2025 financial outlook is not currently expected to be materially impacted by potential tariffs announced by the U.S. Administration on April 2, 2025, even if the exemption for pharmaceuticals were to be removed. This expectation is based on both a significant proportion of U.S. revenue being derived from products which have manufacturing operations in the U.S., and the Company's current global inventory positions. The U.S. and international tariff landscape remains uncertain, and this guidance does not include contemplation of any new tariffs.

News

Guidance

BIIB

Biogen Raises FY2025 Adj EPS Guidance from $14.50-$15.50 to $15.50-$16.00 vs $14.98 Est

The probability that the Federal Reserve could keep interest rates unchanged throughout 2025 surged on Wednesday following Chair Jerome Powell's latest remarks, adding fresh uncertainty to the outlook for monetary policy.
What Happened: On Wednesday, in a post on X, The Kobeissi Letter highlighted the surging odds of there being &#8216;Zero&#8217; rate cuts in 2025 in the prediction market, Kalshi. 
&#8220;The odds of the Fed cutting rates 0 times in 2025 surge to 25% after Powell&#8217;s press conference,&#8221; it says, amid an increasingly hawkish tone by the Fed Chair.
See Also: <a href="https://www.benzinga.com/crypto/cryptocurrency/25/07/46711153/bitcoin-trades-flat-ahead-of-fed-interest-rate-decision-ethereum-dogecoin-gain-analyst-says-next-impulse-will-send-btc-to-130000">Bitcoin Trades Flat Ahead Of Fed Interest Rate Decision; Ethereum, Dogecoin Gain: Analyst Says &#8216;Next Impulse&#8217; Will Send BTC To $130,000</a>
Before Powell's press conference, markets had placed higher odds on two rate cuts. But as of the latest update, &#8220;The odds of 2 rate cuts have fallen from 40% to 33% and the odds of 1 rate cut are up from 24% to 27%,&#8221; the post said.
That shift in sentiment suggests traders and investors are increasingly skeptical that the central bank will deliver any significant easing. The post concludes by saying, &#8220;Rate cuts are being priced out of markets.&#8221;
<figure class="wp-block-embed aligncenter is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">BREAKING: The odds of the Fed cutting rates 0 times in 2025 surge to 25% after Powell&#39;s press conference. The odds of 2 rate cuts have fallen from 40% to 33% and the odds of 1 rate cut are up from 24% to 27%, per Kalshi. Rate cuts are being priced-out of markets. <a href="https://t.co/qtYm7X2oUn">pic.twitter.com/qtYm7X2oUn</a>
&mdash; The Kobeissi Letter (@KobeissiLetter) <a href="https://twitter.com/KobeissiLetter/status/1950643475457994854?ref_src=twsrc%5Etfw">July 30, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Why It Matters: Despite months of relentless pressure from President Donald Trump to cut interest rates, the Federal Open Market Committee (FOMC) has decided to hold <a href="https://www.benzinga.com/markets/macro-economic-events/25/07/46733603/fed-holds-trump-powell-waller-bowman-interest-rates">interest rates steady</a> at 4.25%-4.50% in its July decision on Wednesday. 
Two permanent members of the board, Michelle Bowman and Christopher Waller, both appointed by Trump, dissented during the meeting, arguing in favor of an immediate 25-basis-point rate cut. This marks the first dissent in the FOMC since 1993.
Economist&nbsp;Mohamed El-Erian said that Powell &#8220;sounds more hawkish than many expected on the outlook for policy rates,&#8221; <a href="https://www.benzinga.com/markets/macro-economic-events/25/07/46746117/fed-holds-rates-amid-trumps-demands-for-a-cut-powell-more-hawkish-than-anyone-expected-say-economists-historic-dissent-noted">following his press conference</a> on Wednesday.
Read More:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/equities/25/07/46747607/dow-falls-over-150-points-following-powells-comments-on-rate-cuts-investor-sentiment-declines-but-fear-index-remains-in-greed-zone">Dow Falls Over 150 Points After Powell&#8217;s Comments On Rate Cuts: Investor Sentiment Declines, But Fear Index Remains In &#8216;Greed&#8217; Zone</a></li>
</ul>
Photo courtesy: Domenico Fornas / Shutterstock.com

Federal Reserve

Odds of 'Zero' Fed Rate Cuts In 2025 Surge To 25% After Jerome Powell's Press Conference: 'Rate Cuts Are Being Priced-Out Of Markets'

Earnings

Biogen Q2 2025 Adj. EPS $5.47 Beats $4.06 Estimate, Sales $2.646B Beat $2.319B Estimate

Microsoft Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) is paying distinguished engineers up to $2.4 million annually, according to leaked internal compensation documents, revealing the software giant&#8217;s escalating investment in top-tier technical talent amid Silicon Valley&#8217;s <a href="https://www.benzinga.com/markets/tech/25/07/46654858/alibaba-cloud-founder-says-true-innovation-doesnt-need-expensive-hires-as-mark-zuckerbergs-meta-rolls-out-hundred-million-dollar-packages">heated artificial intelligence hiring war</a>.
<h2 class="wp-block-heading">Pay Structure Spans 14 Levels</h2>
Internal Microsoft documents <a href="https://www.businessinsider.com/microsoft-pay-guidelines-new-hire-offers-exception-2025-7">obtained</a> by Business Insider detail compensation ranges across 14 engineering levels, from entry-level positions starting at $83,000 to Level 70 distinguished engineers earning maximum salaries of $408,000 plus substantial stock awards.
The highest-tier Level 70 engineers receive on-hire stock awards up to $1.9 million and annual stock grants reaching $1.476 million, according to the May-updated guidelines.
Combined with salaries and bonuses, total compensation approaches $2.4 million for elite technical talent.
Microsoft did not immediately respond to&nbsp;<a href="http://pro.benzinga.com/" target="_blank" rel="noreferrer noopener">Benzinga</a>'s request for comment.
See Also: <a href="https://www.benzinga.com/markets/equities/25/07/46747335/palantir-alum-recalls-2020-all-nighter-that-won-over-tyson-foods-after-cto-called-demo-impossible-during-pandemic-supply-chain-crisis">Palantir Alum Recalls 2020 All-Nighter That Won Over Tyson Foods After CTO Called Demo &#8216;Impossible&#8217; During Pandemic Supply Chain Crisis</a>
<h2 class="wp-block-heading">Geographic Pay Differentials Drive Costs Higher</h2>
The company maintains separate &#8220;main&#8221; and &#8220;high&#8221; salary ranges based on location. Engineers at Microsoft&#8217;s Redmond, Washington headquarters fall under the main tier, while those in high-cost areas like San Francisco receive premium compensation packages.
Entry-level engineers (Levels 57-59) earn between $83,000-$163,600, depending on location and experience. Senior engineers begin at Level 63 with salaries ranging from $145,000-$237,600, while principal-level positions start at Level 65 with compensation between $172,800-$282,000.
<h2 class="wp-block-heading">AI Talent War Intensifies Competition</h2>
The compensation structure includes carve-outs for &#8220;competitive situations&#8221; where recruiters can seek approval for higher offers, reflecting the industry&#8217;s fierce competition for AI specialists.
Meta Platforms Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) has reportedly offered packages worth $20 million annually to lure researchers from competitors, including Microsoft, OpenAI and Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>). OpenAI CEO Sam Altman claimed Meta is providing $100 million signing bonuses, <a href="https://www.benzinga.com/markets/tech/25/07/46623904/mark-zuckerbergs-mafioso-poaching-style-at-meta-sparks-ai-talent-war-sam-altman-says-bring-it-on">though Meta executives dispute these figures</a>.
The talent shortage affects approximately 2,000 researchers globally <a href="https://www.benzinga.com/markets/tech/25/07/46623904/mark-zuckerbergs-mafioso-poaching-style-at-meta-sparks-ai-talent-war-sam-altman-says-bring-it-on">capable of building foundational AI models</a>, driving unprecedented compensation inflation across Silicon Valley as companies race to secure artificial intelligence dominance.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/equities/25/07/46745342/samsungs-chip-profits-crash-94-ai-demand-tesla-deal-hbm3e-ramp-offer-hope-for-2h-comeback-as-trump-hits-south-korea-with-15-tariff" target="_blank" rel="noreferrer noopener">Samsung's Chip Profits Crash 94% — AI Demand, Tesla Deal, HBM3E Ramp Offer Hope For 2H Comeback As Trump Hits South Korea With 15% Tariff</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo courtesy: Shutterstock

Tech

AAPL

MSFT

Microsoft Is Paying Up To $2.4 Million For Top Tech Talent—Leaked Docs Show Amid AI Talent Arms Race

NAUT

Nautilus Biotechnology Q2 2025 EPS $(0.12) Beats $(0.15) Estimate

BIGC

BigCommerce Rebrands As Commerce.com, Unifies BigCommerce, Feedonomics And Makeswift To Power AI-Driven Agentic Commerce; Nasdaq Ticker Changes From BIGC To CMRC On August 1

FY2025 and Subsequent Highlights
<ul>
<li>Revenues of $142.1 million, up 45.7% from the prior year period</li>
<li>Gross Margin of 15.0% compared to 13.7% in FY2024</li>
<li>Net income of $5.0 million grew 350% compared to net loss of $2.0 million in FY2024</li>
<li>EBITDA of $10.8 million increased 980% compared to $1.0 million in FY2024</li>
</ul>

GCL Global Holdings Reported FY25 Revenue Of $142.1M, Up 45.7% YoY, EPS Of $0.05

GLXY

GK8 Launches Seamless And Compliant Access To Solana DeFi For OTC Desks, Asset Managers, And Regulated Institutions

Foraco Intl (TSX:<a class="ticker" href="https://www.benzinga.com/stock/FAR#TSX">FAR</a>) reported quarterly earnings of $0.06 per share. This is a 18.18 percent decrease over earnings of $0.08 per share from the same period last year. The company reported quarterly sales of $69.063 million, this is a 11.33 percent decrease over sales of $77.884 million the same period last year.

Earnings Misses

TSX:FAR

Foraco Intl Q2 EPS $0.06 Down From $0.08 YoY.

Mercedes-Benz Group AG (OTC:<a class="ticker" href="https://www.benzinga.com/stock/MBGAF#OTC">MBGAF</a>) (OTC:<a class="ticker" href="https://www.benzinga.com/stock/MBGYY#OTC">MBGYY</a>) has scaled back EV sales in the U.S. and stopped taking new orders, citing low customer demand.
What Happened: The decision affects all variants of the EQS Sedan, EQS SUV, as well as the EQE Sedan and SUV, Business Insider reported <a href="https://www.businessinsider.com/mercedes-benz-electric-vehicle-deliveries-low-demand-trump-tax-credit-2025-7">on</a> Thursday.
Citing a spokesperson for the German automaker, the report suggests that the decision comes after sales for the EVs fell over 25% YoY in the U.S. to 35,027 units compared with last year's 45,843 units.
The automaker has a plant in the state of Alabama as well as one in South Carolina. Mercedes manufactures the EQS and the EQE SUV in Alabama. The report also suggests the company hasn't yet disclosed when orders will be reopened.
During an earnings call with the investors, officials from Mercedes-Benz said that the Trump administration's decision to take away the $7,500 federal EV credit won't have an adverse impact on EV demand as a whole.
"In spite of the announcement that they would take the 7,500 credit away, we don&#8217;t believe that the BEV demand in the United States goes to zero," an official said, adding that the demand may creep upward more slowly than expected.
Why It Matters: The news comes as EV sales in the <a href="https://www.benzinga.com/markets/tech/25/07/46436501/ev-prices-drop-2-8-in-june-as-incentives-surge-amid-tumbling-tesla-sales">U.S. shrank 6%</a> and fell behind other regions like China, where <a href="https://www.benzinga.com/markets/tech/25/07/46408472/electric-vehicle-sales-soar-worldwide-in-june-us-falls-behind-amid-trumps-incentive-rollbacks-report">sales grew 24%</a> in June as the Trump administration announced the axing of EV-related incentives.
Companies like Panasonic Holdings Corp (OTC:<a class="ticker" href="https://www.benzinga.com/stock/PCRFF#OTC">PCRFF</a>) (OTC:<a class="ticker" href="https://www.benzinga.com/stock/PCRHY#OTC">PCRHY</a>) also scaled back plans to <a href="https://www.benzinga.com/markets/tech/25/07/46362407/tesla-sales-slump-prompts-panasonic-to-delay-4-billion-us-battery-plant-expansion-report">ramp up operations</a> at its battery manufacturing facility, citing poor sales in the U.S. experienced by its client, Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>).
In a series of pro-gasoline decisions, the Trump administration also announced a proposal to rescind the <a href="https://www.benzinga.com/news/politics/25/07/46714902/trump-epa-wants-to-overturn-2009-endangerment-finding-that-controls-carbon-emissions-to-end-16-years-of-uncertainty-for-automakers">2009 Endangerment Finding</a>, which has been used as a basis for many emissions norms currently in place.
Repealing the finding could leave no legal pressure on automakers to maintain emission standards, as well as relaxing the CAFE or Corporate Average Fuel Economy norms <a href="https://www.benzinga.com/markets/tech/25/07/46258669/tesla-made-2-76-billion-from-zev-credits-in-2024-in-us-but-trumps-tax-bill-just-killed-this-revenue-stream">could relieve pressure</a> on the companies to invest in electric vehicles.
Elsewhere, the Trump administration reached a deal with the European Union, with the U.S. imposing <a href="https://www.benzinga.com/news/politics/25/07/46679465/trumps-eu-trade-deal-an-act-of-submission-says-french-pm-its-a-dark-day">15% tariffs on goods</a> imported into the country from the EU, lower than the 30% tariffs supposed to kick in from August 1.
Check out more of Benzinga&#8217;s Future Of Mobility coverage by<a href="https://www.benzinga.com/topic/mobility"> following this link.</a>
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/tech/25/07/46746057/ford-ceo-warns-of-2-billion-hit-from-trump-tariffs-in-2025-despite-q2-earnings-surge-says-levies-need-to-be-simplified">Ford CEO Warns Of $2 Billion Hit From Trump Tariffs In 2025 Despite Q2 Earnings Surge, Says Levies Need To Be Simplified</a></li>
</ul>
Photo courtesy: Shutterstock

MERCEDES BENZ GROUP AG by Mercedes Benz Group AG

MBGAF

MERCEDES-BENZ UNSP / ADR by Mercedes Benz Group AG

MBGYY

PCRFF

PCRHY

TSLA

Mercedes-Benz Scales Back EVs In The US, Stops Taking New Orders Citing Low Demand

In addition to the PRIME designation, the EMA's Committee for Medicinal Products for Human Use (CHMP) issued a positive opinion on the EU Orphan Drug Designation (ODD) application for BGB-16673 in WM. A final decision is anticipated in the coming weeks. The U.S. Food and Drug Administration (FDA) also granted Fast Track Designation to BGB-16673 for the treatment of adult patients with relapsed or refractory (R/R) chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL), and adult patients with R/R mantle cell lymphoma (MCL).
The EMA's CHMP granted PRIME designation to BGB-16673 based on data demonstrating its novel mechanism and anti-tumor activity in B-cell malignancies. The CHMP recognized the limited treatment options available for WM patients post-BTK inhibitor therapy and acknowledged the strong biological rationale and promising clinical data for BGB-16673 in this setting, thereby demonstrating the potential to address the unmet medical need

Biotech

Large Cap

Health Care

General

The European Medicines Agency Has Granted PRIority MEdicines (PRIME( Designation To BeOne Medicines' Investigational Bruton's Tyrosine Kinase Degrader, BGB-16673, For Waldenstrom's Macroglobulinemia Previously Treated With A BTK Inhibitor

Instil Bio Notes That ImmuneOnco Reported 80% Partial Response In Squamous NSCLC From Phase 2 Trial Of PD-L1xVEGF Bispecific IMM2510 With Chemo; No Dose-Limiting Toxicities Observed

Integra Lifesciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IART#NASDAQ">IART</a>) affirms FY2025 Adj EPS guidance from $2.19-$2.29 to $2.19-$2.29 vs $2.24 analyst estimate. Narrows FY2025 sales outlook from $1.650 billion-$1.715 billion to $1.655 billion-$1.680 billion vs $1.667 billion estimate.

IART

Integra Lifesciences Affirms FY2025 Adj EPS Guidance of $2.19-$2.29 vs $2.24 Est; Narrows FY2025 Sales Guidance from $1.650B-$1.715B to $1.655B-$1.680B vs $1.667B Est

Integra Lifesciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IART#NASDAQ">IART</a>) is looking for Q3 Adj EPS of $0.40-$0.45 vs $0.58 analyst estimate. sees sales of $410.000 million-$420.000 million vs $418.831 million analyst estimate.

Integra Lifesciences Sees Q3 Adj EPS $0.40-$0.45 vs $0.58 Est; Sees Sales $410.000M-$420.000M vs $418.831M Est

Air Products Narrows FY2025 Adj EPS Guidance from $11.85-$12.15 to $11.90-$12.10 vs $11.98 Est

KBR Lowers Long-term 2027 Financial Targets: Sets Revenue Target To $9B (Prior Target: $11.5B); Sees Operating Cash Flows Of $650M+ (Prior Target: $700M+)

Titan Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TWI#NYSE">TWI</a>) sees Q3 sales of $450.000 million-$475.000 million vs $464.801 million analyst estimate.

Titan Intl Sees Q3 Sales $450.000M-$475.000M vs $464.801M Est

Xcel Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XEL#NASDAQ">XEL</a>) affirms FY2025 Adj EPS guidance from $3.75-$3.85 to $3.75-$3.85 vs $3.81 analyst estimate..

Xcel Energy Affirms FY2025 Adj EPS Guidance of $3.75-$3.85 vs $3.81 Est

Integra Lifesciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IART#NASDAQ">IART</a>) reported quarterly earnings of $0.45 per share which beat the analyst consensus estimate of $0.43 by 4.17 percent. This is a 28.57 percent decrease over earnings of $0.63 per share from the same period last year. The company reported quarterly sales of $415.605 million which beat the analyst consensus estimate of $395.067 million by 5.20 percent. This is a 0.61 percent decrease over sales of $418.175 million the same period last year.

Earnings Beats

Integra Lifesciences Q2 Adj. EPS $0.45 Beats $0.43 Estimate, Sales $415.605M Beat $395.067M Estimate

Legal

Press Releases

Bragar Eagel & Squire, P.C. Is Investigating Red Cat and Construction Partners and Encourages Investors to Contact the Firm

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Construction Partners, Inc. - ROAD

Bragar Eagel & Squire, P.C. Is Investigating Construction Partners and Skyworks and Encourages Investors to Contact the Firm

Construction Partners, Inc. to Participate in the Raymond James Institutional Investors Conference

Construction Partners, Inc. Announces Schedule for Fiscal 2025 Second Quarter Earnings Release and Conference Call

Construction Partners, Inc. Acquires Platform Company in Tennessee

Construction Partners, Inc. Announces Fiscal 2025 Second Quarter Results

Construction Partners, Inc. Recognized as Silver Telly Award Winner For "Follow the Rock" Production

Construction Partners, Inc. Announces Schedule for Fiscal 2025 Third Quarter Earnings Release and Conference Call

RCAT

SWKS

Arcosa

AECOM

Argan

Ameresco

APi Group

Bowman Consulting Group Ltd. - Common Stock

Bowman Consulting Group

Cadeler A/S American Depositary Share (each representing four (4) Ordinary Shares)

Cadeler

Dycom Industries

Everus Construction Group, Inc. Common Stock

Everus Construction Group

EMCOR Group

Comfort Systems USA

Fluor

Great Lakes Dredge & Dock Corporation - Common Stock

Great Lakes Dredge & Dock

Granite Construction Incorporated Common Stock

Granite Const

IES Hldgs

Limbach Holdings

Matrix Service

MasTec

MYR Group

Primoris Services Corporation Common Stock

Primoris Services

Quanta Services

Construction Partners, Inc. - Common Stock

Sterling Infrastructure, Inc. - Common Stock

Sterling Infrastructure

Tutor Perini

AT&T Inc. Depositary Shares, each representing a 1/1,000th interest in a share of 4.750% Perpetual Preferred Stock, Series C

Comments

Construction Partners

Noticias

Últimas noticias sobre Construction Partners (NASDAQ:ROAD) Bolsa

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL